Enhancing Electronic Health Record Data Quality

By Michael Awood

September 6, 2023

Electronic Health Record (EHR) data in biomedical research has seen a significant surge, especially during the COVID-19 pandemic. These rich data records are perfect for complex analyses, including machine learning and artificial intelligence. However, the quality of this data has drawn much concern.

Despite the critical role EHR data plays in healthcare and its frequent use in biomedical research, its quality is often overlooked. This presents a need for a standardised approach to evaluate EHR data quality.

In 1996, Wang and Strong proposed a data quality framework that covered intrinsic, contextual, representational, and accessible data quality. They highlighted that poor data quality could have social and economic impacts. Although their study was not healthcare-specific, their framework focused on the needs of data users, providing a unique perspective.

A 2013 review identified five aspects of EHR data quality – completeness, correctness, concordance, plausibility, and currency. They evaluated these aspects through seven methods, including a gold standard comparison and data element agreement. However, the definitions of these methods and dimensions often overlapped, indicating the need for a more standardised approach. Other data quality frameworks have been suggested, but they differ in their recording and discussion methods. This shows a lack of consensus and adoption.

The development of automated tools for data quality assessment holds the potential to address the data quality challenge. These tools could streamline the process and enhance efficiency. The article suggests that future research should aim at creating tools that improve data integrity and reliability in patient care and research. The potential impact of this work is vast, with implications for disease tracking, patient care, and the advancement of medical science.

It is important that EHRs reflect true and accurate data to minimise potential downstream inefficiencies – due to poor data. This data also feeds into prediction analytics or algorithms for various AI systems, where poor data could result in incorrect analytics and poor outcomes. At present, there are numerous entry points to an EHR due to the multitude of records. Data sources include researchers, medical providers, and increasingly, patients through patient-reported outcome measures (PROMs). Utilising the framework by Wang and Strong could provide a better understanding of data needs, leading to improved health records and health information exchanges (HIEs).

Reference url

Recent Posts

Joint Scientific Consultation EU
Joint Scientific Consultation EU Strategies for Medical Device Companies

By João L. Carapinha

June 19, 2026

The EU Joint Scientific Consultation gives medical device developers a voluntary route to obtain targeted feedback on clinical evidence plans well before formal Joint Clinical Assessment and national reimbursement decisions. Manufacturers of select high-risk technologies can align their developme...
EU Joint Clinical Assessment
Insights on EU Joint Clinical Assessment for High-Risk Medical Devices

By João L. Carapinha

June 19, 2026

EU Joint Clinical Assessment is a distinct, harmonised process that operates separately from CE marking. It produces comparative clinical evidence on selected high-risk devices to support more consistent national reimbursement decisions across EU member states. Insights from the
LesionAttn Skin Cancer AI
LesionAttn Skin Cancer AI Enhances Fairness in Dermatological Diagnostics

By João L. Carapinha

June 19, 2026

LesionAttn Skin Cancer AI tackles a critical flaw in current skin cancer detection tools: models that unconsciously rely on background skin features differing between men and women, producing unequal accuracy across genders. By steering neural networks to focus on the actual lesion instead of the...